| 001 | 1028207 | ||
| 005 | 20250203124529.0 | ||
| 024 | 7 | _ | |a 10.1007/s00259-024-06783-x |2 doi |
| 024 | 7 | _ | |a 1619-7070 |2 ISSN |
| 024 | 7 | _ | |a 1619-7089 |2 ISSN |
| 024 | 7 | _ | |a 10.34734/FZJ-2024-04402 |2 datacite_doi |
| 024 | 7 | _ | |a 38898354 |2 pmid |
| 024 | 7 | _ | |a WOS:001250257200001 |2 WOS |
| 037 | _ | _ | |a FZJ-2024-04402 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Albert, Nathalie L. |0 0000-0003-0953-7624 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0 |
| 260 | _ | _ | |a Heidelberg [u.a.] |c 2024 |b Springer-Verl. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1736944173_1723 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a AbstractPurposeTo provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands.MethodsThis joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO).ResultsPositron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone. SSTR-directed PET imaging can be particularly useful for differential diagnosis, delineation of meningioma extent, detection of osseous involvement, and the differentiation between posttherapeutic scar tissue and tumour recurrence. Moreover, SSTR-peptide receptor radionuclide therapy (PRRT) is an emerging investigational treatment approach for meningioma.ConclusionThese practice guidelines will define procedure standards for the application of PET imaging in patients with meningiomas and related SSTR-targeted PRRTs in routine practice and clinical trials and will help to harmonize data acquisition and interpretation across centers, facilitate comparability of studies, and to collect larger databases. The current document provides additional information to the evidence-based recommendations from the PET/RANO Working Group regarding the utilization of PET imaging in meningiomas Galldiks (Neuro Oncol. 2017;19(12):1576–87). The information provided should be considered in the context of local conditions and regulations. |
| 536 | _ | _ | |a 5252 - Brain Dysfunction and Plasticity (POF4-525) |0 G:(DE-HGF)POF4-5252 |c POF4-525 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Preusser, Matthias |0 0000-0003-3541-2315 |b 1 |
| 700 | 1 | _ | |a Traub-Weidinger, Tatjana |0 0000-0003-1118-926X |b 2 |
| 700 | 1 | _ | |a Tolboom, Nelleke |0 0000-0002-8005-2833 |b 3 |
| 700 | 1 | _ | |a Law, Ian |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Palmer, Joshua D. |0 0000-0003-3311-0129 |b 5 |
| 700 | 1 | _ | |a Guedj, Eric |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Furtner, Julia |0 0000-0001-8258-3681 |b 7 |
| 700 | 1 | _ | |a Fraioli, Francesco |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Huang, Raymond Y. |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Johnson, Derek R. |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Deroose, Christophe M. |0 0000-0002-6080-1577 |b 11 |
| 700 | 1 | _ | |a Herrmann, Ken |0 0000-0002-9662-7259 |b 12 |
| 700 | 1 | _ | |a Vogelbaum, Michael |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Chang, Susan |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Tonn, Joerg-Christian |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Weller, Michael |0 P:(DE-HGF)0 |b 16 |
| 700 | 1 | _ | |a Wen, Patrick Y. |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a van den Bent, Martin J. |0 P:(DE-HGF)0 |b 18 |
| 700 | 1 | _ | |a Verger, Antoine |0 P:(DE-Juel1)171957 |b 19 |
| 700 | 1 | _ | |a Ivanidze, Jana |0 P:(DE-HGF)0 |b 20 |
| 700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 21 |u fzj |
| 773 | _ | _ | |a 10.1007/s00259-024-06783-x |g Vol. 51, no. 12, p. 3662 - 3679 |0 PERI:(DE-600)2098375-X |n 12 |p 3662 - 3679 |t European journal of nuclear medicine and molecular imaging |v 51 |y 2024 |x 1619-7070 |
| 856 | 4 | _ | |y OpenAccess |u https://juser.fz-juelich.de/record/1028207/files/PDF.pdf |
| 856 | 4 | _ | |y OpenAccess |x icon |u https://juser.fz-juelich.de/record/1028207/files/PDF.gif?subformat=icon |
| 856 | 4 | _ | |y OpenAccess |x icon-1440 |u https://juser.fz-juelich.de/record/1028207/files/PDF.jpg?subformat=icon-1440 |
| 856 | 4 | _ | |y OpenAccess |x icon-180 |u https://juser.fz-juelich.de/record/1028207/files/PDF.jpg?subformat=icon-180 |
| 856 | 4 | _ | |y OpenAccess |x icon-640 |u https://juser.fz-juelich.de/record/1028207/files/PDF.jpg?subformat=icon-640 |
| 909 | C | O | |o oai:juser.fz-juelich.de:1028207 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 21 |6 P:(DE-Juel1)143792 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5252 |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-05 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-05 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NUCL MED MOL I : 2022 |d 2024-12-05 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-05 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2024-12-05 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-05 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-05 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NUCL MED MOL I : 2022 |d 2024-12-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-05 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-05 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
Gast ::